Show simple item record

dc.contributor.authorRius Dominguez, Rocio
dc.date.accessioned2021-01-15T01:15:23Z
dc.date.available2021-01-15T01:15:23Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/11343/258698
dc.description© 2020 Rocio Rius Dominguez
dc.description.abstractMitochondrial diseases are the most common metabolic disease, caused by pathogenic variants in both nuclear and mitochondrial genomes. The molecular diagnosis can be challenging, sometimes taking years and requiring multiple invasive and risky diagnostic techniques. Genome sequencing (GS) is an emerging technology that allows the analysis of nuclear and mitochondrial genomes simultaneously. However, the interpretation of data can be complex, and the use of this technology in mitochondrial diseases is limited. This PhD thesis explores the diagnostic utility of GS by investigating retrospective and prospective cohorts of patients with suspected (but molecularly undiagnosed) mitochondrial disease. The thesis is divided into eight chapters. Chapter 1 begins with a general introduction to mitochondrial diseases and associated diagnostic challenges. Chapter 2 describes the subjects and methods used throughout the PhD. Chapters 3 to 6 use trio genome sequencing to analyse a retrospective cohort of patients with paediatric onset mitochondrial disease. In Chapter 3, trio GS uncovers TEFM and COX11 as new candidate mitochondrial disease genes. In Chapter 4, trio GS was useful to identify a deep intronic variant in NBAS, enabling diagnosis of a patient who showed clinical overlap with mitochondrial disease. In Chapter 5, trio GS was used to identify a novel apparently synonymous variant in PNPT1 where in silico and functional studies revealed a splicing defect instead. Clinical information and functional evidence from other patients with PNPT1 variants were studied through an international collaboration to gain a better molecular and clinical understanding of PNPT1-related mitochondrial disease. In Chapter 6, trio GS data was interrogated to study mtDNA inheritance, showing an absence of biparental mitochondrial DNA transmission in the cohort. In Chapter 7, the use of singleton GS data was studied in a prospective cohort of patients with suspected mitochondrial disease. A molecular diagnosis was made in 37% of cases. Examples that show the utility of GS include the identification of a mtDNA variant with low levels of heteroplasmy in blood (NC_012920.1(MT-TL1):m.3243A>T with 2% heteroplasmy), deletions in mtDNA (9kb deletion with 50% heteroplasmy) and nDNA (heterozygous 4.1kb intragenic deletion in AARS2), and the use of GS data to aid in paternity confirmation and variant phasing in a patient with suspected Perrault syndrome and PEX6 variants. Finally, Chapter 8 concludes that GS is an effective tool for the diagnosis of mitochondrial diseases. The diagnostic potential is increased by combining GS with other techniques such as RNA sequencing. Further research is being conducted to assess the cost-benefit of this technology.
dc.rightsTerms and Conditions: Copyright in works deposited in Minerva Access is retained by the copyright owner. The work may not be altered without permission from the copyright owner. Readers may only download, print and save electronic copies of whole works for their own personal non-commercial use. Any use that exceeds these limits requires permission from the copyright owner. Attribution is essential when quoting or paraphrasing from these works.
dc.subjectMitochondrial diseases
dc.subjectMassive parallel sequencing
dc.subjectGenomic sequencing
dc.titleAdvancing the diagnosis of mitochondrial diseases with genomic sequencing
dc.typePhD thesis
melbourne.affiliation.departmentPaediatrics (RCH)
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.affiliation.facultyMelbourne Medical School
melbourne.thesis.supervisornameJohn Christodoulou
melbourne.contributor.authorRius Dominguez, Rocio
melbourne.thesis.supervisorothernameNicole van Bergen
melbourne.thesis.supervisorothernameDavid Thorburn
melbourne.thesis.supervisorothernameAlison Compton
melbourne.tes.fieldofresearch1310509 Genomics
melbourne.tes.fieldofresearch2320213 Medical genetics (excl. cancer genetics)
melbourne.tes.fieldofresearch3320507 Metabolic medicine
melbourne.tes.fieldofresearch4310199 Biochemistry and cell biology not elsewhere classified
melbourne.accessrightsThis item is embargoed and will be available on 2023-01-15.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record